Decorin deficiency leads to impaired angiogenesis in injured mouse cornea

Journal of Vascular Research

Volumn 41, Issue 6, 2004, Pages 499-508

  Schönherr, Elke ^a,b   Sunderkötter, Cord ^a,c   Schaefer, Liliana ^a   Thanos, Solon ^a   Grässel, Susanne ^a,d   Oldberg, Åke ^e   Iozzo, Renato V ^f   Young, Marian F ^g   Kresse, Hans ^a  

^a UNIVERSITY HOSPITAL MÜNSTER   (Germany)

^b CARDIFF UNIVERSITY   (United Kingdom)

^c UNIVERSITY HOSPITAL ULM   (Germany)

^d UNIVERSITY HOSPITAL REGENSBURG   (Germany)

^e LUND UNIVERSITY   (Sweden)

^f THOMAS JEFFERSON UNIVERSITY   (United States)

^g NATIONAL INSTITUTE OF DENTAL AND CRANIOFACIAL RESEARCH   (United States)

Author keywords

Collagen; Corneal epithelium; Extracellular matrix; Inflammation; Vascular endothelium

Indexed keywords

BIGLYCAN; DECORIN; FIBROMODULIN; PROTEOGLYCAN;

ANGIOGENESIS; ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; CAPILLARY; CAUTERIZATION; CONTROLLED STUDY; CORNEA EPITHELIUM; CORNEA INJURY; CORNEA LIMBUS; CORNEA STROMA; EXPERIMENTAL MODEL; GENE TARGETING; INFLAMMATION; KNOCKOUT MOUSE; MOLECULAR BIOLOGY; MOLECULAR DYNAMICS; MOUSE; NONHUMAN; PRIORITY JOURNAL; TISSUE DISTRIBUTION;

ANIMALS; CORNEA; CORNEAL STROMA; ENDOTHELIUM, CORNEAL; EXTRACELLULAR MATRIX PROTEINS; KERATITIS; LIMBUS CORNEAE; MALE; MICE; MICE, MUTANT STRAINS; NEOVASCULARIZATION, PHYSIOLOGIC; PROTEOGLYCANS;

EID: 10644234507     PISSN: 10181172     EISSN: None     Source Type: Journal    
DOI: 10.1159/000081806     Document Type: Article

References (42)

1. Li J, Zhang YP, Kirsner RS: Angiogenesis in wound repair: Angiogenic growth factors and the extracellular matrix. Microsc Res Tech 2003;60:107-114.
2. Kresse H, Schönherr E: Proteoglycans of the extracellular matrix and growth control. J Cell Physiol 2001;189:266-274.
3. Iozzo RV: The family of the small leucine-rich proteoglycans: Key regulators of matrix assembly and cellular growth. Crit Rev Biochem Mol Biol 1997;32:141-174.
4. Iozzo RV: Matrix proteoglycans: From molecular design to cellular function. Annu Rev Biochem 1998;67:609-652.
5. Funderburgh JL: Keratan sulfate: Structure, biosynthesis and function. Glycobiology 2000;10:951-958.
6. Hocking AM, Shinomura T, McQuillan DJ: Leucine-rich repeat glycoproteins of the extracellular matrix. Matrix Biol 1998;17:1-19.
7. Weber IT, Harrison RW, Iozzo RV: Model structure of decorin and implications for collagen fibrillogenesis. J Biol Chem 1997;271:31767-31770.
8. Scott JE: Proteodermatan and proteokeratan sulfate (decorin, lumican, fibromodulin) proteins are horseshoe shaped. Implications for their interactions with collagen. Biochemistry 1996;35:8795-8799.
9. Keene DR, San Antonio JD, Mayne R, McQuillan DJ, Sarris G, Santoro SA, Iozzo RV: Decorin binds near the C-terminus of type I collagen. J Biol Chem 2000;275:21801-21804.
10. Meek KM, Fullwood NJ: Corneal and scleral collagens - A microscopist's perspective. Micron 2001;32:261-272.
11. Schönherr E, Hausser H, Beavan L, Kresse H: Decorin-type I collagen interaction. Presence of separate core protein-binding domains. J Biol Chem 1995b;270:8877-8883.
12. Wiberg C, Hedbom E, Khairullina A, Lamande SR, Oldberg Å, Timpl R, Mörgelin M, Heinegård D: Biglycan and decorin bind close to the N-terminal region of the collagen VI triple helix. J Biol Chem 2001;276:18947-18952.
13. Corsi A, Xu T, Chen XD, Boyde A, Liang J, Mankani M, Sommer B, Iozzo RV, Eichstetter I, Robey PG, Bianco P, Young MF: Phenotypic effects of biglycan deficiency are linked to collagen fibril abnormalities, are synergized by decorin deficiency, and mimic Ehlers-Danloslike changes in bone and other connective tissues. J Bone Miner Res 2002;17:1180-1189.
14. Schönherr E, Witsch-Prehm P, Harrach B, Robenek H, Rauterberg J, Kresse H: Interaction of biglycan with type I collagen. J Biol Chem 1995a;270:2776-2783.
15. Svensson L, Narlid I, Oldberg Å: Fibromodulin and lumican bind to the same region on collagen type I fibrils. FEBS Lett 2000;470:178-182.
16. Hildebrand A, Romaris M, Rasmussen LM, Heinegård D, Twardzik DR, Border WA, Ruoslahti E: Interaction of the small interstitial proteoglycans biglycan, decorin and fibromodulin with transforming growth factor-ß. Biochem J 1994;302:527-534.
17. Border WA, Noble NA, Yamamoto T, Harper JR, Yamaguchi Y, Pierschbacher MD, Ruoslahti E: Natural inhibitor of transforming growth factor-ß protects against scarring in experimental kidney disease. Nature 1992;360:361-364.
18. Kolb M, Margetts PJ, Sime PJ, Gauldie J: Proteoglycans decorin and biglycan differentially modulate TGF-ß-mediated fibrotic responses in the lung. Am J Physiol Lung Cell Mol Physiol 2001;280:L1327-L1334.
19. DeLuca A, Santra M, Baldi A, Giordano A, Iozzo RV: Decorin-induced growth suppression is associated with up-regulation of p21Cip1/Waf1, an inhibitor of cyclin-dependent kinases. J Biol Chem 1996;271:18961-18965.
20. Moscatello DK, Santra M, Mann DM, McQuillan DJ, Wong AJ, Iozzo RV: Decorin suppresses tumor cell growth by activating the epidermal growth factor receptor. J Clin Invest 1998;101:406-412.
21. Santra M, Eichstetter I, Iozzo RV: An antioncogenic role for decorin. Down-regulation of ErbB2 leads to growth suppression and cytodifferentiation of mammary carcinoma cells. J Biol Chem 2000;275:35153-35161.
22. Järveläinen HT, Kinsella MG, Wight TN, Sandell LJ: Differential expression of small chondroitin/ dermatan sulfate proteoglycans, PG-I/ biglycan and PG-II/decorin, by vascular smooth muscle and endothelial cells in culture. J Biol Chem 1991;266:23274-23281.
23. Schönherr E, O'Connell BC, Schittny J, Robenek H, Fastermann D, Fisher LW, Plenz G, Vischer P, Young MF, Kresse H: Paracrine or virus-mediated induction of decorin expression by endothelial cells contributes to tube formation and prevention of apoptosis in collagen lattices. Eur J Cell Biol 1999;78:44-45.
24. Nelimarkka L, Salminen H, Kuopio T, Nikkari S, Ekfors T, Laine J, Pelliniemi L, Järveläinen H: Decorin is produced by capillary endothelial cells in inflammation-associated angiogenesis. Am J Pathol 2001;158:345-353.
25. Schönherr E, Schaefer L, O'Connell BC, Kresse H: Matrix metalloproteinase expression by endothelial cells in collagen lattices changes during co-culture with fibroblasts and upon induction of decorin expression. J Cell Physiol 2001;187:37-47.
26. Sunderkötter C, Beil W, Roth J, Sorg C: Cellular events associated with inflammatory angiogenesis in the mouse cornea. Am J Pathol 1991;138:931-939.
27. Danielson KG, Baribault H, Holmes DF, Graham H, Kadler KE, Iozzo RV: Targeted disruption of decorin leads to abnormal collagen fibril morphology and skin fragility. J Cell Biol 1997;136:729-743.
28. Xu T, Bianco P, Fisher LW, Longenecker G, Smith E, Goldstein S, Bonadio J, Boskey A, Heegaard AM, Sommer B, Satomura K, Dominguez P, Zhao C, Kulkarni AB, Robey PG, Young MF: Targeted disruption of the biglycan gene leads to an osteoporosis-like phenotype in mice. Nat Genet 1998;20:78-82.
29. Svensson L, Aszodi A, Reinholt FP, Fässler R, Heinegård D, Oldberg Å: Fibromodulin-null mice have abnormal collagen fibrils, tissue organization, and altered lumican deposition in tendon. J Biol Chem 1999;274:9636-9647.
30. Chakravarti S, Magnuson T, Lass JH, Jepsen KJ, LaMantia C, Carroll H: Lumican regulates collagen fibril assembly: Skin fragility and corneal opacity in the absence of lumican. J Cell Biol 1998;141:1277-1286.
31. Schaefer L, Hausser H, Altenburger M, Ugorcakova J, August C, Fisher LW, Schaefer RM, Kresse H: Decorin, biglycan and their endocytosis receptor in rat renal cortex. Kidney Int 1998;54:1529-1541.
32. Schaefer L, Macakova K, Raslik I, Micegova M, Gröne HJ, Schönherr E, Robenek H, Echtermeyer FG, Grässel S, Bruckner P, Schaefer RM, Iozzo RV, Kresse H: Absence of decorin adversely influences tubulointerstitial fibrosis of the obstructed kidney by enhanced apoptosis and increased inflammatory reaction. Am J Pathol 2002;160:1181-1191.
33. Fisher LW, Stubbs JT 3rd, Young MF: Antisera and cDNA probes to human and certain animal model bone matrix noncollagenous proteins. Acta Orthop Scand Suppl 1995;266:61-65.
34. Grant DS, Yenisey C, Rose RW, Tootell M, Santra M, Iozzo RV: Decorin suppresses tumor cell-mediated angiogenesis. Oncogene 2002;21:4765-4777.
35. Roth J, Vogl T, Sorg C, Sunderkötter C: Phagocyte-specific S100 proteins: A novel group of proinflammatory molecules. Trends Immunol 2003;24:155-158.
36. Frosch M, Strey A, Vogl T, Wulffraat NM, Kuis W, Sunderkötter C, Harms E, Sorg C, Roth J: Myeloid-related proteins 8 and 14 are specifically secreted during interaction of phagocytes and activated endothelium and are useful markers for monitoring disease activity in pauciarticular-onset juvenile rheumatoid arthritis. Arthritis Rheum 2000;43:628-637.
37. Cursiefen C, Rummelt C, Kuchle M: Immunohistochemical localization of vascular endothelial growth factor, transforming growth factor alpha, and transforming growth factor beta1 in human corneas with neovascularization. Cornea 2000;19:526-533.
38. Soo C, Hu FY, Zhang X, Wang Y, Beanes SR, Lorenz HP, Hedrick MH, Mackool RJ, Plaas A, Kim SJ, Longaker MT, Freymiller E, Ting K: Differential expression of fibromodulin, a transforming growth factor-beta modulator, in fetal skin development and scarless repair. Am J Pathol 2000;157:423-433.
39. Xaus J, Comalada M, Cardo M, Valledor AF, Celada A: Decorin inhibits macrophage colony-stimulating factor proliferation of macrophages and enhances cell survival through induction of p27(Kip1) and p21(Waf1). Blood 2001;98:2124-2133.
40. Sunderkötter C, Steinbrink K, Goebeler M, Bhardwaj R, Sorg C: Macrophages and angiogenesis. J Leukocyte Biol 1994;55:410-422.
41. Davies Cde L, Melder RJ, Munn LL, Mouta-Carreira C, Jain RK, Boucher Y: Decorin inhibits endothelial migration and tube-like structure formation: Role of thrombospondin-1. Microvasc Res 2001;62:26-42.
42. Tralhão JG, Schaefer L, Micegova M, Evaristo C, Schönherr E, Kayal S, Veiga-Fernandes H, Danel C, Aresta S, Iozzo RV, Kresse H, Lemarchand P: In vivo selective and distant killing of cancer cells using adenovirus-mediated decorin gene transfer. FASEB J 2003;17:464-466.